These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23832319)

  • 21. Image Quality Assessment of 2D
    Hausmann D; Liu J; Budjan J; Reichert M; Ong M; Meyer M; Smakic A; Grimm R; Strecker R; Schoenberg SO; Wang X; Attenberger UI
    Anticancer Res; 2018 Feb; 38(2):969-978. PubMed ID: 29374729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer?
    Jang JK; Lee CM; Park SH; Kim JH; Kim J; Lim SB; Yu CS; Kim JC
    Korean J Radiol; 2021 Sep; 22(9):1451-1461. PubMed ID: 34132075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy.
    Monguzzi L; Ippolito D; Bernasconi DP; Trattenero C; Galimberti S; Sironi S
    Eur J Radiol; 2013 Feb; 82(2):234-40. PubMed ID: 23122748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The application of the golden-angle radial sparse parallel technique in T restaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Zhou M; Huang H; Gong T; Chen M
    Abdom Radiol (NY); 2024 Aug; 49(8):2960-2970. PubMed ID: 38822854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary and post-chemoradiotherapy staging using MRI in rectal cancer: the role of diffusion imaging in the assessment of perirectal infiltration.
    Fornell-Perez R; Perez-Alonso E; Porcel-de-Peralta G; Duran-Castellon A; Vivas-Escalona V; Aranda-Sanchez J; Gonzalez-Dominguez MC; Rubio-Garcia J; Aleman-Flores P; Lozano-Rodriguez A; Orihuela-de-la-Cal ME; Loro-Ferrer JF
    Abdom Radiol (NY); 2019 Nov; 44(11):3674-3682. PubMed ID: 31332499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer.
    Elmi A; Hedgire SS; Covarrubias D; Abtahi SM; Hahn PF; Harisinghani M
    Clin Radiol; 2013 Oct; 68(10):e524-31. PubMed ID: 23830776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion-weighted MRI to assess response to chemoradiotherapy in rectal cancer: main interpretation pitfalls and their use for teaching.
    Lambregts DMJ; van Heeswijk MM; Delli Pizzi A; van Elderen SGC; Andrade L; Peters NHGM; Kint PAM; Osinga-de Jong M; Bipat S; Ooms R; Lahaye MJ; Maas M; Beets GL; Bakers FCH; Beets-Tan RGH
    Eur Radiol; 2017 Oct; 27(10):4445-4454. PubMed ID: 28409357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI prediction of pathological response in locally advanced rectal cancer: when apparent diffusion coefficient radiomics meets conventional volumetry.
    Palmisano A; Di Chiara A; Esposito A; Rancoita PMV; Fiorino C; Passoni P; Albarello L; Rosati R; Del Maschio A; De Cobelli F
    Clin Radiol; 2020 Oct; 75(10):798.e1-798.e11. PubMed ID: 32712007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy.
    Kim SH; Lee JM; Hong SH; Kim GH; Lee JY; Han JK; Choi BI
    Radiology; 2009 Oct; 253(1):116-25. PubMed ID: 19789256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
    Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
    World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological correlation with diffusion restriction on diffusion-weighted imaging in patients with pathological complete response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results.
    Jang KM; Kim SH; Choi D; Lee SJ; Park MJ; Min K
    Br J Radiol; 2012 Sep; 85(1017):e566-72. PubMed ID: 22422387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopy and MRI for restaging early rectal cancer after neoadjuvant treatment.
    Stijns RCH; Leijtens J; de Graaf E; Bach SP; Beets G; Bremers AJA; Beets-Tan RGH; de Wilt JHW
    Colorectal Dis; 2023 Feb; 25(2):211-221. PubMed ID: 36104011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer.
    Kluza E; Rozeboom ED; Maas M; Martens M; Lambregts DM; Slenter J; Beets GL; Beets-Tan RG
    Eur Radiol; 2013 Jan; 23(1):253-61. PubMed ID: 22777621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interpretation of Complete Tumor Response on MRI Following Chemoradiotherapy of Rectal Cancer: Inter-Reader Agreement and Associated Factors in Multi-Center Clinical Practice.
    Kim HY; Cho SH; Jang JK; Kim B; Lee CM; Lim JS; Moon SK; Oh SN; Seo N; Park SH
    Korean J Radiol; 2024 Apr; 25(4):351-362. PubMed ID: 38528693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Yang L; Xia C; Liu D; Fang X; Pan X; Ma L; Wu B
    Acta Radiol; 2020 Sep; 61(9):1155-1164. PubMed ID: 31924105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
    Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
    [No Abstract]   [Full Text] [Related]  

  • 38. Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI.
    Nie K; Shi L; Chen Q; Hu X; Jabbour SK; Yue N; Niu T; Sun X
    Clin Cancer Res; 2016 Nov; 22(21):5256-5264. PubMed ID: 27185368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative analysis of diffusion weighted imaging to predict pathological good response to neoadjuvant chemoradiation for locally advanced rectal cancer.
    Tang Z; Zhang XY; Liu Z; Li XT; Shi YJ; Wang S; Fang M; Shen C; Dong E; Sun YS; Tian J
    Radiother Oncol; 2019 Mar; 132():100-108. PubMed ID: 30825957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of diffusion kurtosis and diffusivity from baseline staging MRI as predictive biomarkers for response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Bates DDB; Mazaheri Y; Lobaugh S; Golia Pernicka JS; Paroder V; Shia J; Zheng J; Capanu M; Petkovska I; Gollub MJ
    Abdom Radiol (NY); 2019 Nov; 44(11):3701-3708. PubMed ID: 31154482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.